NCT06754761 2025-01-01Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of CeralasertibAstraZenecaPhase 1 Not yet recruiting8 enrolled
NCT02630199 2022-06-15Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory CancerSamsung Medical CenterPhase 1 Completed65 enrolled
NCT03669601 2021-06-04ATRiUMCambridge University Hospitals NHS Foundation TrustPhase 1 Unknown55 enrolled